In a murine prostate cancer model, Waitz et al. observed that cryoablation of tumors plus anti-CTLA-4 increased the CD8+ and CD4+ infiltration of secondary tumors, attaining infiltration of 1 CD4+ and CD8+ lymphocyte per 1000 tumor cells (9). The gene discussed is CD8A; the disease is prostate carcinoma.